Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamic Medical TechnologiesROCO:4138 +0.20%82 Return-on-Tangible-Equity is 8.99% as of Dec. 2025, which is 4% below its 10-year median of 9.37. GuruFocus rates ROCO:4138 with a GF Score™ of 82/100 and a GF Value™ of NT$74.20 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Dynamic Medical Technologies ranks better than 66.23% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Dynamic Medical Technologies's annualized net income for the quarter that ended in Dec. 2025 was NT$146 Mil. Dynamic Medical Technologies's average shareholder tangible equity for the quarter that ended in Dec. 2025 was NT$1,629 Mil. Therefore, Dynamic Medical Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 8.99%.
The historical rank and industry rank for Dynamic Medical Technologies's Return-on-Tangible-Equity or its related term are showing as below:
ROCO:4138'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.36 Med: 9.37 Max: 14.43
Current: 9.91
During the past 13 years, Dynamic Medical Technologies's highest Return-on-Tangible-Equity was 14.43%. The lowest was 8.36%. And the median was 9.37%.
ROCO:4138's Return-on-Tangible-Equity is ranked better than 66.23% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.055
vs ROCO:4138: 9.91
Dynamic Medical Technologies (ROCO:4138) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Dynamic Medical Technologies Return-on-Tangible-Equity Related Terms
Dynamic Medical Technologies Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamic Medical Technologies Return-on-Tangible-Equity Chart
ROCO:4138 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Dynamic Medical Technologies's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamic Medical Technologies Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynamic Medical Technologies's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Dynamic Medical Technologies's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 8.99% mean?
Dynamic Medical Technologies (ROCO:4138) has a Return-on-Tangible-Equity of 8.99% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dynamic Medical Technologies and its competitors. This is near median its historical median of 9.37. Over the past decade, Dynamic Medical Technologies' Return-on-Tangible-Equity has ranged from 8.36 to 14.43. According to the industry distribution chart, Dynamic Medical Technologies ranks #256 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 33.8%.
Is Dynamic Medical Technologies' Return-on-Tangible-Equity too high?
Dynamic Medical Technologies' current Return-on-Tangible-Equity of 8.99% is near median its 10-year median of 9.37. Over the past 10 years, this metric has ranged from a low of 8.36 to a high of 14.43. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.06. Dynamic Medical Technologies' value of 8.99% is 121.7% above this industry median. Based on the distribution chart, Dynamic Medical Technologies ranks #256 out of 758 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dynamic Medical Technologies has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Dynamic Medical Technologies ranks #256 out of 758 companies for Return-on-Tangible-Equity. This puts Dynamic Medical Technologies in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.06. Dynamic Medical Technologies' value of 8.99% is 121.7% above this benchmark. Historically, Dynamic Medical Technologies' own Return-on-Tangible-Equity has ranged from 8.36 to 14.43 over the past decade. While the company's 10-year median is 9.37 vs. the industry median of 4.06, Dynamic Medical Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.06, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamic Medical Technologies's current Return-on-Tangible-Equity of 8.99% is 121.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dynamic Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamic Medical Technologies's current Return-on-Tangible-Equity is 8.99%, which is near median its own 10-year median of 9.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$74.20, compared to a current price of NT$50.90 — trading 31.4% below its estimated fair value. The current Return-on-Tangible-Equity is 8.99%, which is near median its 10-year median of 9.37 and 121.7% above the Medical Devices & Instruments industry median of 4.06. Dynamic Medical Technologies' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current Return-on-Tangible-Equity is 8.99% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?
Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued.
The current stock price of NT$50.90 is trading 31.4% below its estimated GF Value™ of NT$74.20.
GuruFocus considers Dynamic Medical Technologies to be Significantly Undervalued.
Key valuation signals for ROCO:4138:
Return-on-Tangible-Equity: 8.99% (near median its 10-year median of 9.37)
GF Value™: NT$74.20 vs. price of NT$50.90 (31.4% below fair value)
Industry Position: 121.7% above the Medical Devices & Instruments median (#256 of 758)
No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
82GF Score
Get the complete analysis for ROCO:4138
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4138 has been successfully added to your 
